Sources: 1BitterDB, 4ClinicalTrials, 7Cochrane Library, 10DGIdb, 14DrugBank, 29HMDB, 33IUPHAR, 46NDF-RT, 50Novoseek, 56PharmGKB, 68UMLSSee all MalaCards sources |
Drugs for Interstitial Lung Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 446)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Prednisolone | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 1153 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol | MLS001304083 MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 2 | | Iron | approved | Phase 4 | 1123 | 7439-89-6 | 23925 | 02583_FLUKA 12310_ALDRICH 12310_RIEDEL 129048-51-7 14067-02-8 161135-39-3 190454-13-8 195161-83-2 199281-22-6 209309_ALDRICH 209309_SIAL 255637_ALDRICH 266213_ALDRICH 266256_ALDRICH 267945_ALDRICH 267953_ALDRICH 26Fe 338141_ALDRICH 356808_ALDRICH 356824_ALDRICH 356832_ALDRICH 39344-71-3 3ZhP 413054_ALDRICH 443783-52-6 44890_ALDRICH 44890_FLUKA 675141-17-0 70884-35-4 73135-38-3 7439-89-6 8011-79-8 8053-60-9 AC1L2N38 ATW 230 ATW 432 Ancor B Ancor en 80/150 Armco iron Atomel 28 Atomel 300M200 Atomel 500M Atomel 95 Atomiron 44MR Atomiron 5M Atomiron AFP 25 Atomiron AFP 5 C00023 C3518_SIAL C3518_SIGMA CCRIS 1580 CHEBI:18248 CID23925 Carbonyl iron Copy Powder CS 105-175 D007501 DB01592 DSP 1000 DSP 128B DSP 135 DSP 135C DSP 138 Diseases (animal), iron overload Diseases, iron overload EF 1000 EF 250 EFV 200/300 EFV 250 EFV 250/400 EINECS 231-096-4 | Ed-In-Sol Eisen Electrolytic iron F 60 (metal) FE FT 3 (element) Fe Fe-40 Fe1+ Feronate Ferretts Ferro-Caps Ferro-Time Ferrousal Ferrovac E Ferrum Ferrum metallicum GS 6 HF 2 (element) HL (iron) HQ (metal) HS (iron) HS 4849 HSDB 604 Hemocyte Hierro Hoeganaes ATW 230 Hoeganaes EH IRMM524A_FLUKA IRMM524B_FLUKA IRON Iron (Fe) Iron (Fe1+) Iron ion (Fe+) Iron ion(1+) Iron monocation Iron powder Iron standard for AAS Iron(1+) Iron(1+) ion Iron(III) nitrate solution Iron, carbonyl Iron, electrolytic Iron, elemental Iron, ion (Fe1+) Iron, ion (Fe1+) (8CI,9CI) Iron, reduced LOHA LS-3196 MolPort-003-925-001 NC 100 PZh-1M3 PZh-2 PZh1M1 PZh2M PZh2M1 PZh2M2 PZh3 PZh3M PZh4M PZhO Reduced iron Remko SUY-B 2 Siderol UNII-E1UOL152H7 Vitedyn-Slo Yieronia fer ferrous iron hierro | |
| | 3 | | Methylprednisolone | approved, vet_approved | Phase 4, Phase 2, Phase 3, Phase 1 | 1153 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone |
| | 4 | | Sirolimus | approved, investigational | Phase 4, Phase 3 | 1896 | 53123-88-9 | 5284616, 6436030, 46835353 | (-)-Rapamycin (-)-rapamycin 1fkb 1pbk 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine 23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29 3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone 53123-88-9 A422989, NSC226080 AC-722 AC1L1JH9 AC1L7MJ9 AC1L9ZMV AY 22989 AY-22989 AY22989 Ambotz53123-88-9 Antibiotic AY 22989 BIDD:PXR0165 Bio1_000293 Bio1_000782 Bio1_001271 Bio2_000375 Bio2_000855 BiomolKI2_000084 C07909 C51H79NO13 CBiol_002007 CCRIS 9024 CHEBI:100923 CHEBI:9168 CHEMBL413 CID10213190 CID10795871 CID11949238 CID11959112 CID313006 CID478951 CID5040 CID5284616 CID5358081 CID5374464 CID5460439 CID5497196 CID5924240 CID6436030 CID6610270 CID6610346 CID6711160 CID6713081 CID9833581 CID9854379 CID9854380 CID9962926 CID9962928 D00753 DB00877 DE-109 DivK1c_006936 | FT-0082351 HMS2089A21 HSDB 7284 KBio1_001880 KBio2_000410 KBio2_002978 KBio2_005546 KBio3_000779 KBio3_000780 KBioGR_000410 KBioSS_000410 LCP-Siro LMPK06000003 LS-143290 MLS000028373 MS-R001 MolMap_000043 MolPort-003-959-433 NCGC00021305-05 NCI60_001851 NCIMech_000355 NSC 226080 NSC226080 Perceiva QTL1_000069 R0395_SIAL R0395_SIGMA RAP RAPA RPM Rapammune Rapamune Rapamune (TN) Rapamycin Rapamycin (TN) Rapamycin C-7, analog 4 Rapamycin Immunosuppressant Drug Rapamycin from Streptomyces hygroscopicus S1039_Selleck SIIA 9268A SILA 9268A SILA9268A SMP1_000255 SMR000058564 Sirolimus Sirolimus (RAPAMUNE) Sirolimus (USAN/INN) Sirolimus [USAN:BAN:INN] Sirolimus, Rapamune,Rapamycin SpecPlus_000840 UNII-W36ZG6FT64 UNM-0000358684 WY-090217 Wy 090217 heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy nchembio.100-comp4 nchembio.2007.42-comp2 nchembio.79-comp1 nchembio762-comp1 nchembio883-comp3 rapamycin sirolimus |
| | 5 | | Cyclophosphamide | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 2829 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Anhydrous cyclophosphamide Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 | DB00531 DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide |
| | 6 | | Everolimus | approved | Phase 4, Phase 3 | 1896 | 159351-69-6 | 6442177 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy 07741_FLUKA 159351-69-6 40-O-(2-hydroxyethyl)-rapamycin 42-O-(2-Hydroxyethyl)rapamycin Afinitor CERTICAN(R) CHEMBL1201755 Certican D02714 DB01590 | Everolimus Everolimus (JAN/USAN/INN) Everolimus [USAN] LS-143292 MolPort-003-847-342 MolPort-003-925-588 NCGC00167512-01 NVP-RAD-001 RAD 001 RAD-001 RAD-001C RAD001 RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus S1120_Selleck SDZ-RAD UNII-9HW64Q8G6G Zortress everolimus |
| | 7 | | Methotrexate | approved | Phase 4, Phase 3, Phase 2 | 1518 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-Methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan | Methopterin Methotextrate Methotrate Methotrexat Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Rheumatrex Trexall | |
| | 8 | | Prednisone | approved, vet_approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1359 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl | Juvason Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 9 | | Iloprost | approved, investigational | Phase 4, Phase 2, Phase 3 | 77 | 78919-13-8 | 6443959 | (16R,S)-Methyl-18,18,19,19-tetradehydro-6a-carbaprostaglandin I(sub 2) (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid (5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-methyloct-1-en-6-yn-1-yl]hexahydropentalen-2(1H)-ylidene]pentanoic acid (5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid (5Z)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3R)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid (E)-(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-ynyl)-delta(sup 2(1H),delta)-pentalenevaleric acid (E)-5-(3aS,4R,5R,6aS)-5-Hydroxy-4((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-inyl)perhydropentalen-2-yliden)valeriansaeure 73873-87-7 78919-13-8 AC1NSK5T AC1O5JIJ AC1O5JP3 AC1Q1J28 ACT-213105 C22H32O4 CHEMBL138694 CHEMBL236025 CHEMBL494 CID10937300 CID11639089 CID5311181 CID6435293 CID6435378 CID9885245 | CID9975807 Ciloprost D02721 E-1030 Endoprost HMS2090A19 ILOPROST Ilomedin Ilomedine Iloprost Iloprost (INN) Iloprost [BAN:INN] Iloprostum Iloprostum [Latin] L000996 LS-101845 NCGC00181784-01 PDSP2_001536 SH-401 UNII-JED5K35YGL Ventavis Ventavis (TN) ZK 36374 ZK-36374 ZK-363775 [3H]-Iloprost |
| | 10 | | Mycophenolic acid | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 939 | 24280-93-1 | 446541 | (e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid Acide mycophenolique Acido micofenolico Acidum mycophenolicum | Melbex Micofenolico acido Mycophenoic acid Mycophenolate Mycophenolsäure Myfortic |
| | 11 | | Mycophenolate mofetil | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 939 | 128794-94-5 | 5281078 | 115007-34-6 128794-94-5 140401-05-4 2-Morpholinoethyl (4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-Morpholinoethyl (e)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate 2-morpholin-4-ylethyl (4E)-6-[4-hydroxy-7-methyl-6-(methyloxy)-3-oxo-1,3-dihydro-2-benzofuran-5-yl]-4-methylhex-4-enoate 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl -3-oxo-5-isobenzofuranyl)-4-methyl-, 2-(4-morpholinyl)ethyl ester, (4E) AC-1562 AC1NQXZW AC1Q6O6X AR-1J6939 BB_NC-2566 C07908 C23H31NO7 CHEMBL1456 CID5281078 CellCept CellCept, RS 61443, TM-MMF, Mycophenolate mofetil Cellcept Cellcept (TN) D00752 DB00688 HMS2090A03 | HSDB 7436 I01-0898 I06-1947 LS-172272 LS-75572 ME-MPA MMF MMF CellCept(TM) MolPort-000-883-800 Munoloc Mycophenolate mofetil (JAN/USAN) Mycophenolic acid morpholinoethyl ester Mycophenylate mofetil NCGC00159459-02 NCGC00159459-03 NSC724229 R-99 RS 61443 RS-61443 RS-61443-190 S1501_Selleck TL8000648 TM-MMF UNII-9242ECW6R0 ZINC21297660 mycophenolate mofetil | |
| | 12 | | Benzocaine | approved | Phase 4, Phase 2, Phase 3, Phase 1 | 1892 | 1994-09-7, 94-09-7 | 2337 | (p-(Ethoxycarbonyl)phenylamine 06952_FLUKA 112909_ALDRICH 112909_SIAL 1333-08-0 23239-88-5 23239-88-5 (hydrochloride) 4 Aminobenzoic Acid Ethyl Ester 4-(Ethoxycarbonyl)aniline 4-(Ethoxycarbonyl)phenylamine 4-14-00-01129 (Beilstein Handbook Reference) 4-Aminobenzoate 4-Aminobenzoic acid 4-Aminobenzoic acid ethyl ester 4-Aminobenzoic acid, ethyl ester 4-Carbethoxyaniline 4-amino-benzoic acid ethyl ester 4-aminobenzoic acid ethyl ester 71123-91-6 94-09-7 94-09-7 (Parent) A0271 AB00051923 AC1L1DGC AC1Q341A AC1Q64JE AE-562/40377256 AI3-02081 AKOS000119763 AR-1H9065 Acetate, Benzocaine Aethoform Aethylium paraminobenzoicum Amben ethyl ester Americaine Anaesthan-syngala Anaesthesin Anaesthesinum Anaesthin Anestezin Anestezin [Russian] Anesthesin Anesthesine Anesthone BB_SC-0019 BPBio1_001017 BRD-K75466013-001-05-2 BRN 0638434 BSPBio_000923 BSPBio_001908 Baby Anbesol Bensokain Benzoak Benzocaina Benzocaina [INN-Spanish] Benzocaine Benzocaine (USP/INN) Benzocaine Acetate Benzocaine Formate Benzocaine Hydrobromide Benzocaine Hydrochloride Benzocaine Methanesulfonate Benzocaine [INN:BAN] Benzocainum Benzocainum [INN-Latin] Benzoic acid, 4-amino-, ethyl ester Benzoic acid, 4-amino-, ethyl ester, hydrochloride Benzoic acid, amino-, ethyl ester Benzoic acid, p-amino-, ethyl ester C07527 CAS-94-09-7 CHEBI:116735 CHEMBL278172 CID2337 Caswell No. 430A Chloraseptic D001566 D00552 DB01086 Dermoplast Diet Ayds DivK1c_000932 E1501_SIGMA EINECS 202-303-5 EPA Pesticide Chemical Code 097001 ETHYL-P-AMINOBENZOATE Ethoform Ethoforme Ethyl 4-aminobenzoate Ethyl 4-aminobenzoate hydrochloride Ethyl 4-aminobenzoic acid Ethyl Aminobenzoate Ethyl PABA | Ethyl aminobenzoate Ethyl aminobenzoate (JP15) Ethyl aminobenzoate (VAN) Ethyl aminobenzoic acid Ethyl p-Aminobenzoate Ethyl p-Aminophenylcarboxylate Ethyl p-aminobenzenecarboxylate Ethyl p-aminobenzoate Ethyl p-aminobenzoic acid Ethyl p-aminophenylcarboxylate Ethylester kyseliny p-aminobenzoove Ethylester kyseliny p-aminobenzoove [Czech] Ethylis aminobenzoas Formate, Benzocaine HMS1570O05 HMS1920G09 HMS2091M11 HMS502O14 HSDB 7225 Hurricaine Hydrobromide, Benzocaine Hydrochloride, Benzocaine I05-0204 IDI1_000932 Identhesin KBio1_000932 KBio2_000474 KBio2_003042 KBio2_005610 KBio3_001408 KBioGR_000658 KBioSS_000474 Keloform LS-35847 MLS001331704 MLS002153970 Methanesulfonate, Benzocaine MolPort-000-871-526 NCGC00016352-01 NCGC00094598-01 NCGC00094598-02 NINDS_000932 NSC 122792 NSC 41531 NSC41531 NSC4688 Norcain Norcaine Norcainum Oprea1_750694 Oprea1_827402 Ora-jel Orabase-B Orthesin Otocain Outgro Parathesin Parathesin (TN) Parathesine Prestwick0_000712 Prestwick1_000712 Prestwick2_000712 Prestwick3_000712 Prestwick_991 SMR000059025 SPBio_000134 SPBio_002844 SPECTRUM1500139 STK043620 Slim Mint Gum Solarcaine Solu H Spectrum2_000117 Spectrum3_000314 Spectrum4_000249 Spectrum5_000860 Spectrum_000074 Topcaine UNII-U3RSY48JW5 WLN: ZR DVO2 ZINC12358719 benzocaine ethylaminobenzoate-4 h-4-abz-oet nchembio.182-comp4 p-(Ethoxycarbonyl)aniline p-Aminobenzoate p-Aminobenzoic acid p-Aminobenzoic acid ethyl ester p-Aminobenzoic acid, ethyl ester p-Aminobenzoic ethyl ester p-Carbethoxyaniline p-Ethoxycarboxylic Aniline p-Ethoxycarboxylic aniline | |
| | 13 | | rituximab | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1654 | 174722-31-7 | 10201696 | AntiCD20 IDEC-102 IDEC-C2B8 | Ig gamma-1 chain C region MabThera Mabthera Rituxan rituximab |
| | 14 | | alemtuzumab | approved, investigational | Phase 4, Phase 2, Phase 1 | 303 | 216503-57-0 | | | | 15 | | Daclizumab | approved, investigational | Phase 4, Phase 2 | 98 | 152923-56-3 | | Dacliximab Daclizumab beta | |
| | 16 | | Miconazole | approved, investigational, vet_approved | Phase 4, Phase 3, Phase 1, Phase 2 | 3624 | 22916-47-8 | 4189 | (+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole 1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole 1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole 1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole 1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole 22832-87-7 (NITRATE) 22916-47-8 75319-47-0 AB00053500 AC1L1HM1 AKOS001574474 Aflorix(nitrate) Albistat(nitrate) Andergin(nitrate) BPBio1_000279 BRD-A82396632-001-03-0 BRD-A82396632-008-02-7 BRN 0965511 BSPBio_000253 BSPBio_002033 CCRIS 7924 CHEBI:6923 CHEMBL91 CID4189 CPD-4501 Conofite(nitrate) D00416 DB01110 Dactarin Daktarin IV Daktarin iv DivK1c_000156 EINECS 245-324-5 Epi-Monistat(nitrate) Femizol-M Florid(nitrate) Gyno-Daktar(nitrate) HMS1568M15 HMS2090B21 I14-14342 IDI1_000156 Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI) KBio1_000156 KBio2_001445 KBio2_004013 KBio2_006581 KBio3_001533 KBioGR_000581 KBioSS_001445 LS-78378 Lotrimin AF(nitrate) MCZ MJR 1762 MLS002222203 Micantin (nitrate) Miconasil Nitrate | Miconazol Miconazol [INN-Spanish] Miconazole Miconazole (JP15/USP/INN) Miconazole 3 Miconazole 3 Combination Pack Miconazole 7 Combination Pack Miconazole [USAN:BAN:INN:JAN] Miconazole nitrate salt Miconazole-7 Miconazolo Miconazolo [DCIT] Miconazolum Miconazolum [INN-Latin] Micozole Minostate MolPort-002-557-553 Monazole 7 Monista (nitrate) Monistat Monistat (TN) Monistat 1 Combination Pack Monistat 3 Dual-Pak Monistat 3 Vaginal Ovules Monistat 5 Tampon Monistat 7 Dual-Pak Monistat 7 Vaginal Suppositories Monistat Dual- PAK Monistat IV Monistat iv (TN) Monistat iv (tn) Monistat-Derm NCI60_001353 NCI60_001380 NINDS_000156 NSC 170986 NSC169434 NSC170986 Novo-Miconazole Vaginal Ovules Oprea1_091955 Prestwick0_000067 Prestwick1_000067 Prestwick2_000067 Prestwick3_000067 Prestwick_335 R 18134 R-14,889 SMR001307249 SPBio_000976 SPBio_002174 STK834405 STOCK1S-93556 Spectrum2_001048 Spectrum3_000507 Spectrum4_000061 Spectrum5_001297 Spectrum_000965 UNII-7NNO0D7S5M Vusion Zimycan imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI) miconazole | |
| | 17 | | Azathioprine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 165 | 446-86-6 | 2265 | 446-86-6 55774-33-9 (hydrochloride salt) 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech] 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(Methyl-p-nitro-5-imidazolyl)thiopurine 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine 6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine A 4638 A2593_SIAL A4638_SIAL A4638_SIGMA AB00443544 AB00443544-03 AC-4230 AC1L1DAL AC1Q3Z1F AI-981/34845012 AI3-50290 Azamun Azamun [Czech] Azanin Azasan Azasan (TN) Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine Azathioprin Azathioprine (JP15/USP/INN) Azathioprine Sodium Azathioprine [USAN:INN:BAN:JAN] Azathioprine sodium Azathioprinum Azathioprinum [INN-Latin] Azathiopurine Azatioprin Azatioprina Azatioprina [INN-Spanish] Azothioprine B. W. 57-322 BPBio1_000054 BRD-K32821942-001-05-6 BRD-K60324116-001-01-5 BSPBio_000048 BSPBio_001876 BW 57-322 BW 57322 BW-57-322 C06837 C9H7N7O2S CAS-446-86-6 CBDivE_013132 CCRIS 62 CHEBI:2948 CHEMBL1542 CID2265 CPD000427366 Ccucol ChemDiv1_002659 Cytostatics D00238 DB00993 DivK1c_000586 EINECS 207-175-4 EU-0100027 FT-0083532 HMS1568C10 HMS1920E17 | HMS2091K19 HMS501N08 HMS594I19 HSDB 7084 IDI1_000586 Immuran Imuran Imuran (TN) Imuran (tn) Imurek Imurel KBio1_000586 KBio2_000464 KBio2_002427 KBio2_003032 KBio2_004995 KBio2_005600 KBio2_007563 KBio3_001376 KBio3_002906 KBioGR_000646 KBioGR_002427 KBioSS_000464 KBioSS_002433 LS-123 Lopac-A-4638 Lopac0_000027 MLS001049307 Methylnitroimidazolylmercaptopurine MolPort-000-745-914 MolPort-000-764-262 MolPort-003-665-485 Muran NCGC00015060-01 NCGC00015060-02 NCGC00015060-04 NCGC00015060-12 NCGC00090836-01 NCGC00090836-02 NCGC00090836-03 NCGC00090836-04 NCGC00090836-05 NCGC00090836-06 NCGC00094593-01 NCGC00094593-02 NCGC00094593-03 NCI-C03474 NINDS_000586 NSC 39084 NSC-39084 NSC39084 Oprea1_375441 Oprea1_533384 Oprea1_633462 Prestwick0_000094 Prestwick1_000094 Prestwick2_000094 Prestwick3_000094 Prestwick_41 S1721_Selleck SAM002589938 SDCCGMLS-0065415.P001 SMR000427366 SPBio_000255 SPBio_001987 SPECTRUM1500133 STK831906 STOCK1S-20293 STOCK1S-27186 Spectrum2_000068 Spectrum3_000308 Spectrum4_000243 Spectrum5_000848 Spectrum_000064 Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl) UNII-MRK240IY2L WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW ZINC04258316 [Methyl(nitroimidazolyl)mercaptopurine] azathioprine azatiopr in cMAP_000046 | |
| | 18 | | Cyclosporine | approved, investigational, vet_approved | Phase 4, Phase 3 | 915 | 79217-60-0, 59865-13-3 | 5284373, 6435893 | 1c5f 1cyn 30024_FLUKA 30024_SIGMA 59865-13-3 79217-60-0 AC1L1EQW AC1NQXJE AC1NR4C4 AC1NUQK3 AC1NUZNC AC1O5KOG AC1Q2UDG Ambap59865-13-3 Ambotz59865-13-3 Antibiotic S 7481F1 BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA BPBio1_000496 BRD-A64290322-001-01-6 BRD-A69815203-001-04-3 BRD-K13533483-001-03-0 BSPBio_000450 BSPBio_001596 BSPBio_003186 C 3662 C05086 C1832_SIGMA C3662_SIGMA C62H111N11O12 CB-01-09 MMX CHEBI:106343 CHEBI:328305 CHEBI:4031 CHEMBL160 CHEMBL386389 CHEMBL532318 CID2909 CID5280754 CID5284373 CID5458585 CID5497195 CID6435893 CSA CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)) CYCLOSPORIN A, USP Ciclosporin Ciclosporin (JP15) Ciclosporina Ciclosporine Ciclosporinum Cipol N Cipol-N Consupren Consupren S CsA CsA & IFN.alpha. CyA Cyclokat Cyclosporin Cyclosporin A Cyclosporin A & IFN.alpha. Cyclosporin A Implant Cyclosporin A, Tolypocladium inflatum Cyclosporine (USP) Cyclosporine A Cyclosporine [USAN] D00184 DE-076 DivK1c_000871 EU-0100242 Equoral GNF-Pf-2808 Gengraf Gengraf (TN) HMS1569G12 HMS1791P18 HMS1921L20 HMS1989P18 HMS2089A09 HMS2092F06 HMS502L13 Helv Chim Acta 60: 1568 (1977) | I06-0379 I06-0966 IDI1_000871 KBio1_000871 KBio2_000780 KBio2_003348 KBio2_005916 KBio3_002686 KBioGR_001898 KBioSS_000780 LMPK14000003 LS-257 LS-58836 Lopac0_000242 MLS000028376 MLS001333756 MLS002153454 MLS002207033 Mitogard Modusik-A MolPort-000-760-988 MolPort-005-934-008 MolPort-006-705-994 NCGC00093704-01 NCGC00093704-02 NCGC00093704-03 NCGC00093704-04 NCGC00093704-05 NCGC00093704-06 NCGC00093704-07 NCGC00093704-08 NCGC00164258-01 NCGC00164258-02 NINDS_000871 NSC290193 Neoplanta Neoral Neoral (TN) NeuroSTAT Nova-22007 OL 27-400 OL-27400 OLO-400 Papilock Prestwick2_000435 Prestwick3_000435 Prestwick_731 Pulminiq Ramihyphin A Restasis Restasis (TN) S-Neoral S1514_Selleck SDZ-OXL 400 SMR000058578 SPBio_001467 SPECTRUM1502202 ST-603 Sandimmun Sandimmun Neoral Sandimmune Sandimmune (TN) Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine Sang-2000 Sang-35 SangCyA Sangcya Sigmasporin Sigmasporin Microoral Spectrum2_001484 Spectrum3_001593 Spectrum4_001279 Spectrum5_001628 Spectrum_000300 TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A) Vekacia Zyclorin cyclophorine cyclosporin A cyclosporine from Tolypocladium inflatum (Trichoderma polysporin) nchembio.184-comp6 nchembio.301-comp5 nchembio.342-comp1 | |
| | 19 | | Tacrolimus | approved, investigational | Phase 4, Phase 2, Phase 3 | 1074 | 104987-11-3 | 445643, 439492 | (-)-FK 506 (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone 104987-11-3 109581-93-3 (Hydrate) 15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone, 3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN AC-1182 AC1L1K7H AC1L97GB AC1L9IBU AKOS005145901 Advagraf Ambap104987-11-3 Ambap5429 Anhydrous tacrolimus BCBcMAP01_000194 BRD-K35452788-001-02-1 BSPBio-001279 BSPBio_001279 Bio-0921 Bio2_000470 Bio2_000950 C01375 C44H69NO10 CCRIS 7124 CHEBI:100924 CHEBI:61049 CHEMBL1200738 CID11158639 CID11556866 CID439492 CID445643 CID5372 CID5472317 CID6426916 CID6436007 CID6473866 CID6536850 CID6610362 CID6912836 CID9832283 CID9853905 CID9918805 CID9940643 CID9963169 CPD-10016 CPD000466356 D08556 DB00864 DivK1c_001040 FK 506 FK-506 FK5 FK506 FR 900506 FR-900506 | FR900506 FT-0082660 Fk-506 Fujimycin Graceptor HMS1362O21 HMS1792O21 HMS1990O21 HMS2051C18 HMS2093M19 HMS503O21 IDI1_001040 IDI1_002225 K506 KBio1_001040 KBio2_000619 KBio2_003187 KBio2_005755 KBio3_001097 KBio3_001098 KBioGR_000619 KBioSS_000619 L 679934 L-679934 LCP-Tacro LMPK04000003 LS-64247 MLS000759471 MLS001424054 Modigraf MolPort-003-666-518 NCGC00163470-01 NCGC00163470-02 NCGC00163470-03 NCGC00163470-04 NCGC00179232-01 NChemBio.2007.16-comp1 NINDS_001040 NSC717865 Prograf Prograf (TN) Protopic Protopy S5003_Selleck SAM001246677 SMR000466356 Tacarolimus Tacrolimus (INN) Tacrolimus (Prograf?) Tacrolimus (anhydrous) Tacrolimus anhydrous Tacrolimus hydrate Tacrolimus, anhydrous Tsukubaenolide UNII-Y5L2157C4J nchembio.2007.23-comp2 tacrolimus tacrolimus hydrate | |
| | 20 | | Bosentan | approved, investigational | Phase 4, Phase 2, Phase 3 | 103 | 147536-97-8 | 104865 | -5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide 147536-97-8 174227-18-0 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide AC-148 AC1L2XN2 Actelion Bosentan Bosentan (INN) Bosentan [USAN:INN:BAN] Bosentan hydrate C27H29N5O6S CHEBI:51450 CHEMBL957 CID104865 D07538 DB00559 | EN002863 HMS2090N14 I06-1873 KS-5062 L001086 LS-31532 MolPort-003-845-300 NCGC00167440-01 PDSP1_001731 PDSP2_001714 Ro 47-0203 Ro 47-0203/039 Ro-47-0203 Ro-47-0203/029 Ro-47-0203/039 TL8001039 Tracleer UNII-XUL93R30K2 bosentan bosentanum bosentán p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide p-tert-Butyl-N-[6-(2-hydroxyethoxy) |
| | 21 | | Nintedanib | approved | Phase 4, Phase 3, Phase 2 | 113 | 656247-17-5 | 56843413 | | Vargatef methyl (3Z)-3-[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}anilino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate nintedanib | |
| | 22 | | Propofol | approved, investigational, vet_approved | Phase 4 | 1028 | 2078-54-8 | 4943 | 2, 6-Diisopropylphenol 2,6 Diisopropylphenol 2,6-Bis(1-methylethyl)phenol 2,6-Bis(Isopropyl)-phenol 2,6-DIISOPROPYLPHENOL 2,6-Diisopropyl phenol 2,6-Diisopropylphenol 2,6-bis(1-methylethyl)-phenol 2,6-di(propan-2-yl)phenol 2078-54-8 28449-97-0 4-06-00-03435 (Beilstein Handbook Reference) 50356-15-5 AB00513968 AC-2038 AC1L1J9Y AC1Q1OUI AI3-26295 AM-149 Abbott Brand of Propofol Alpha Brand of Propofol Ampofol Aquafol Astra Brand of Propofol AstraZeneca Brand of Propofol BIDD:GT0436 BPBio1_000950 BPBio1_000969 BRD-K82255054-001-03-5 BRN 1866484 BSPBio_000862 Biomol-NT_000248 Braun Brand of Propofol C07523 C12H18O CAS-2078-54-8 CCRIS 9000 CHEBI:44915 CHEMBL526 CID4943 CPD-11437 CPD000059151 Curamed Brand of Propofol D00549 D015742 D0617 D126608 D126608_ALDRICH DB00818 DDS-04F Diisopropylphenol Dipravan Diprivan Diprivan (TN) Diprivan Injectable emulsion Disoprivan Disoprofol EINECS 218-206-6 EU-0100437 Fresenius Brand of Propofol Fresenius Kabi Brand of Propofol Fresofol HMS1570L04 HMS2089O21 HMS2094E17 | HSDB 7123 ICI 35,868 ICI 35868 ICI-35,868 ICI-35868 ICI35,868 ICI35868 InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H Ivofol Jsp004266 Juste Brand of Propofol LS-996 Lopac-D126608 Lopac0_000437 MLS001066348 MLS001335999 MLS002454360 MolPort-001-794-517 NCGC00015389-01 NCGC00015389-02 NCGC00015389-04 NCGC00015389-09 NCGC00091538-01 NCGC00091538-02 NCGC00091538-03 NCGC00091538-04 NCGC00091538-05 NCGC00091538-06 NSC 5105 NSC5105 PFL Parnell Brand of Propofol Pisa Brand of Propofol Prestwick0_000931 Prestwick1_000931 Prestwick2_000931 Prestwick3_000931 Propofol Propofol (JAN/USAN/INN) Propofol Abbott Propofol Fresenius Propofol IDD-D Propofol MCT Propofol Rovi Propofol [USAN:INN:BAN] Propofol(2,6-Diisopropylphenol) Propofol-Lipuro Propofolum Propofolum [Latin] Rapinovet Recofol Rovi Brand of Propofol S01-0189 SAM002264610 SMR000059151 SPBio_003031 SPECTRUM1505022 ST50405911 Schering Brand of Propofol UNII-YI7VU623SF W505102_ALDRICH ZD-0859 ZINC00968303 Zeneca Brand of Propofol ghl.PD_Mitscher_leg0.558 nchembio.552-comp7 propofol |
| | 23 | | Menthol | approved | Phase 4, Phase 1 | 2353 | 2216-51-5 | 16666 | (− ()-Menthol (+)-Neo-menthol (+)-p-Menthan-3-ol (+-)-(1R*,3R*,4S*)-Menthol (+-)-Menthol (+/-)-Menthol (+/-)-p-Menthan-3-ol (-)-(1R,3R,4S)-Menthol (-)-Menthyl alcohol (-)-menthol (-)-p-Menthan-3-ol (-)-trans-p-Menthan-cis-ol (1R)-(-)-Menthol (1R,2S,5R)-(-)-menthol (1R,2S,5R)-Menthol (1R,3R,4S)-(-)-MENTHOL (1R,3R,4S)-(-)-Menthol (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol (1S, 2S, 5R)-(+)-Neomenthol (1S,2R,5R)-(+)-Isomenthol (1S,2R,5S)-(+)-Menthol (1S,2R,5S)-Menthol (1alpha,2beta,5alpha)-5-Methyl-2(1-methylethyl)cyclohexanol (1r,2s,5r)-(-)-menthol (L)-MENTHOL (R)-(-)-Menthol (r)-(-)-menthol )-Menthol --MENTHOL 1-Menthol 1490-04-6 15356-60-2 15356-70-4 15785_RIEDEL 15785_SIAL 19863P 2-Isopropyl-5-methylcyclohexanol 20747-49-3 2216-51-5 3-p-Menthol 4-Isopropyl-1-methylcyclohexan-3-ol 491-02-1 5-Methyl-2-(1-methylethyl)-cyclohexanol 5-Methyl-2-(1-methylethyl)cyclohexanol 5-methyl-2-(propan-2-yl)cyclohexanol 5-methyl-2-propan-2-ylcyclohexan-1-ol 551376_ALDRICH 551376_FLUKA 588733_ALDRICH 613290_ALDRICH 613290_FLUKA 63660_FLUKA 63670_ALDRICH 63670_FLUKA 63975-60-0 6C6A4A8C-A054-468C-A1F0-F29E39838CF2 89-78-1 98167-53-4 AC1L1B2E AC1L28FR AC1Q1NQ2 AC1Q2QQM AI3-08161 AI3-52408 AKOS000119740 AR-1J3337 BB_NC-0057 BRN 1902288 BRN 3194263 BSPBio_003062 C00400 C10H20O CCRIS 3728 CCRIS 375 CCRIS 4666 CCRIS 9231 CHEBI:15409 CHEBI:545611 CHEMBL256087 CHEMBL470670 CID1254 CID16666 Caswell No. 540 D-(-)-Menthol D-p-Menthan-3-ol D00064 D008610 D04849 D04918 DB00825 DivK1c_000820 EINECS 201-939-0 EINECS 207-724-8 EINECS 216-074-4 EINECS 218-690-9 EINECS 239-387-8 EINECS 239-388-3 EPA Pesticide Chemical Code 051601 FEMA No. 2665 Fisherman's friend lozenges Fisherman's friend lozenges (TN) HMS1922G13 HMS2092L14 HMS502I22 | HSDB 5662 HSDB 593 Headache crystals Hexahydrothymol I06-1216 I14-7371 IDI1_000820 KBio1_000820 KBio2_000785 KBio2_003353 KBio2_005921 KBio3_002562 KBioSS_000785 L-(-)-Menthol L-(-)-menthol L-Menthol L-menthol LMPR0102090001 LS-2353 LS-57201 LS-886 LS-89531 LS-89533 Levomenthol Levomenthol [INN:BAN] Levomentholum Levomentholum [INN-Latin] Levomentol M0321 M0545 M2772_SIAL MENTHOL MLS002207256 Menthacamphor Menthol Menthol (USP) Menthol (VAN) Menthol natural Menthol natural, brazilian Menthol racemic Menthol racemique Menthol racemique [French] Menthol solution Menthol, (1alpha,2beta,5alpha)-Isomer Menthomenthol Menthyl alcohol MolPort-000-849-729 MolPort-001-793-392 NCGC00159382-02 NCGC00159382-03 NCGC00164247-01 NCGC00164247-02 NCI-C50000 NINDS_000820 NOOLISFMXDJSKH-KXUCPTDWBX NSC 2603 NSC 62788 NSC2603 NSC62788 Neoisomenthol Peppermint camphor RACEMIC MENTHOL U.S.P. Racementhol Racementhol [INN:BAN] Racementholum Racementholum [INN-Latin] Racementol Racementol [INN-Spanish] Racemic menthol Robitussin Cough Drops SDCCGMLS-0066659.P001 SMR001306785 SPBio_000869 SPECTRUM1503134 STK802468 Spectrum2_000855 Spectrum3_001561 Spectrum5_001060 Spectrum_000305 Tra-kill tracheal mite killer U.S.P. Menthol U.S.p. Menthol UNII-BZ1R15MTK7 UNII-L7T10EIP3A UNII-YS08XHA860 W266507_ALDRICH W266523_ALDRICH W266590_ALDRICH WLN: L6TJ AY1&1 BQ D1 WLN: L6TJ AY1&1 DQ D1 -L ZINC01482164 cis-1 ,3-trans-1,4-(+-)-menthol cis-1,3-trans-1,4-(+-)-menthol d,l-Menthol d-Menthol d-Neomenthol dl-3-p-Menthanol dl-Menthol dl-Menthol (JP15) l-(-)-Menthol l-Menthol l-Menthol (JP15) l-Menthol (TN) l-Menthol (natural) nchembio862-comp1 p-Menthan-3-ol rac-Menthol |
| | 24 | | Gefitinib | approved, investigational | Phase 4, Phase 3 | 351 | 184475-35-2 | 123631 | 184475-35-2 4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline 4-(3'-chloro-4'-Fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline 6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine AC-1556 AC1L3X0A AKOS000280752 BCB03_000781 Bio-0046 C419708 CCRIS 9011 CHEBI:49668 CHEMBL939 CID123631 CU-00000000396-1 D01977 DB00317 DB07998 EC-000.2409 EN002708 FT-0081035 Gefitini Gefitinib Gefitinib (JAN/USAN/INN) Gefitinib [USAN] Gefitinib, Iressa, ZD1839 Gelfitinib HMS2089B19 I01-1227 | IRE Iressa Iressa (TN) Iressa(TM) Irressat K00240 KBioSS_002241 Kinome_3321 Kinome_3322 LS-139916 MolPort-000-883-335 N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine N-(3-chloro-4-Fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine NCGC00159455-02 NCGC00159455-03 NSC715055 S1025_Selleck STK621310 UNII-S65743JHBS ZD 1839 ZD-1839 ZD-1839, Iressa, Gefitinib ZD1839 ZINC19632614 gefitinib nchembio.117-comp18 nchembio866-comp14 |
| | 25 | | Nicotine | approved | Phase 4, Phase 1, Phase 2 | 1050 | 54-11-5 | 942, 89594 | (− (+)-Nicotine (-)-3-(1-Methyl-2-pyrrolidyl)pyridine (-)-3-(N-Methylpyrrolidino)pyridine (-)-Nicotine (-)-Nicotine solution (2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine (R)-3-(1-Methyl-2-pyrrolidinyl)pyridine (R,S)-Nicotine (S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE (S)-(-)-Nicotine (S)-(−)-nicotine (S)-3-(1-methylpyrrolidin-2-yl)pyridine (S)-3-(N-methylpyrrolidin-2-yl)pyridine (S)-Nicotine (−)-nicotine )-1-Methyl-2-(3-pyridyl)pyrrolidine )-Nicotine )-Nicotine solution 1-Methyl-2-(3-pyridal)-Pyrrolidine 1-Methyl-2-(3-pyridal)-pyrrolidene 1-Methyl-2-(3-pyridiyl)pyrrolidine 1-Methyl-2-(3-pyridyl)pyrrolidine 1uw6 2'-beta-H-Nicotine 3-(1-Methyl-2-pyrollidinyl)pyridine 3-(1-Methyl-2-pyrrolidinyl)-Pyridine 3-(1-Methyl-2-pyrrolidinyl)pyridine 3-(1-Methylpyrrolidin-2-yl)pyridine 3-(2-(N-methylpyrrolidinyl))pyridine 3-(N-Methylpyrollidino)pyridine 3-(N-Methylpyrrolidino)pyridine 3-(N-methylpyrollidino)pyridine 3-N-Methylpyrrolidine 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine 36733_FLUKA 36733_RIEDEL 434F7990-3240-4A43-ACEC-E6CC1E495FA0 46343_FLUKA 46343_RIEDEL 54-11-5 AC1L3I79 AC1Q3ZOC AI3-03424 BB_NC-0777 BIDD:GT0599 BRD-K05395900-322-02-1 Black Leaf Black Leaf 40 C00745 CCRIS 1637 CHEBI:17688 CHEMBL3 CID89594 CPD000059074 Campbell's Nico-Soap Caswell No. 597 Commit D-Nicotine D03365 DL-tetrahydronicotyrine Destruxol Destruxol Orchid Spray EINECS 200-193-3 ENT 3,424 EPA Pesticide Chemical Code 056702 Emo-Nik Flux Maag Fumeto bac Fumetobac HSDB 1107 Habitrol Habitrol (TN) L(-)-nicotine L(−)-nicotine L-3-(1-Methyl-2-pyrrolidyl)pyridine | L-Nicotine LS-202 MLS001055457 MLS001335905 Mach-Nic Methyl-2-pyrrolidinyl)pyridine Micotine MolPort-000-744-731 N3876_SIGMA N5511_FLUKA N5511_SIGMA NCGC00090693-01 NCGC00090693-02 NCGC00090693-03 NCGC00090693-04 NCGC00090693-05 NCGC00090693-06 NCGC00090693-07 NCT NICOTINE AND SALTS NSC 5065 NSC97238 Niagara P.A. Dust Nic-Sal Nico-Dust Nico-Fume Nicocide Nicoderm Nicoderm Cq Nicoderm Patch Nicorette Nicorette Plus Nicotin Nicotina Nicotina [Italian] Nicotine Nicotine (USP) Nicotine (compounds related to) Nicotine Alkaloid Nicotine Patch Nicotine Polacrilex Nicotine [BSI:ISO] Nicotine [UN1654] Nicotine [UN1654] [Poison] Nicotine [USAN] Nicotrol Nicotrol Inhaler Nicotrol Ns Nictoine patch Nikotin Nikotin [German] Nikotyna Nikotyna [Polish] Ortho N-4 Dust Ortho N-5 Dust PDSP1_000113 PDSP1_000465 PDSP2_000463 PDSP2_000555 Prostep R)-(+)-Nicotine RCRA waste no. P075 RCRA waste number P075 SAM002564224 SDCCGMLS-0066911.P001 SMR000059074 Tendust Transdermal Nicotine UN1654 a -N-Methylpyrrolidine a-N-Methylpyrrolidine alpha-N-Methylpyrrolidine beta-Pyridyl-alpha-N-methyl pyrrolidine beta-Pyridyl-alpha-N-methylpyrrolidine bmse000105 delta-Nicotine nicotine nicotine replacement patch |
| | 26 | | Sulfamethoxazole | approved | Phase 4, Phase 3 | 158 | 723-46-6 | 5329 | 129378-89-8 3-(Para-Aminophenylsulphonamido)-5-methylisoxazole 3-(p-Aminobenzenesulfonamido)-5-methylisoxazole 3-(p-Aminophenylsulfonamido)-5-methylisoxazole 3-(para-Aminophenylsulphonamido)-5-methylisoxazole 3-Sulfanilamido-5-methylisoxazole 3-Sulphanilamido-5-methylisoxazole 4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide 4-Amino-N-(5-methyl-3-isoxazolyl)-Benzenesulfonamide 4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide 4-Amino-N-[5-methyl-3- isoxazolyl]benzenesulfonamide 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide 4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide 46850_RIEDEL 5-Methyl-3-sulfanilamidoisoxazole 5-Methyl-3-sulfanylamidoisoxazole 5-Methyl-3-sulfonylamidoisoxazole 5-Methyl-3-sulphanil-amidoisoxazole 723-46-6 A047 AB00052099 AC-11118 AC1L1K42 AC1Q2J5R AKOS000200952 ALBB-002089 ARONIS018156 Apo-Sulfamethoxazole Azo Gantanol Azo-Gantanol Azo-gantanol BAS 00836086 BB_SC-1251 BIDD:GT0731 BPBio1_000081 BRD-K28494619-001-05-0 BRN 0226453 BSPBio_000073 BSPBio_002028 Bactrim Bactrimel C07315 C10H11N3O3S CAS-723-46-6 CCRIS 567 CHEBI:9332 CHEMBL443 CID5329 CPD000058223 D00447 D013420 DB01015 DivK1c_000649 EINECS 211-963-3 Gamazole Gantanol Gantanol (TN) Gantanol (tn) Gantanol-DS HMS1568D15 HMS1921A21 HMS2092K03 HMS502A11 HMS561O18 HSDB 3186 I01-0154 IDI1_000649 InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13) KBio1_000649 KBio2_001474 KBio2_004042 KBio2_006610 KBio3_001528 KBioGR_000749 KBioSS_001474 LS-1620 MLS000069732 MLS001055354 MLS001074165 MS 53 Maybridge1_007190 Metoxal MolPort-000-145-787 N'-(5-Methyl-3-isoxazole)sulfanilamide | N'-(5-Methyl-3-isoxazolyl)-Sulfanilamide N'-(5-Methyl-3-isoxazolyl)sulfanilamide N'-(5-Methylisoxazol-3-yl)sulphanilamide N(Sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide N1-(5-Methyl-3-isoxazolyl)sulfanilamide N1-(5-Methyl-3-isoxazolyl)sulphanilamide N1-(5-Methylisoxazol-3-yl)sulfanilamide N1-(5-methyl-3-isoxazolyl)-Sulfanilamide NCGC00016533-01 NCGC00016533-02 NCGC00021995-03 NCGC00021995-04 NCGC00021995-05 NINDS_000649 NSC 147832 NSC147832 N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide Oprea1_114486 Oprea1_285680 Prestwick0_000177 Prestwick1_000177 Prestwick2_000177 Prestwick3_000177 Prestwick_453 Radonil Ro 4-2130 Ro 6-2580/11 Ro-4-2130 S0361 S1915_Selleck S7507_FLUKA S7507_SIGMA SAM002554930 SIM SMR000058223 SMX SPBio_000896 SPBio_001994 SPECTRUM1500550 STK007988 SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE) Septran Simsinomin Sinomin Solfametossazolo Solfametossazolo [DCIT] Spectrum2_000788 Spectrum3_000584 Spectrum4_000345 Spectrum5_000982 Spectrum_000994 Sulfamethalazole Sulfamethoxazol Sulfamethoxazole Sulfamethoxazole (JP15/USP/INN) Sulfamethoxazole [USAN:INN:JAN] Sulfamethoxazole sodium Sulfamethoxazole(USAN) Sulfamethoxazolum Sulfamethoxazolum [INN-Latin] Sulfamethoxizole Sulfamethylisoxazole Sulfametoxazol Sulfametoxazol [INN-Spanish] Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI) Sulfisomezole Sulpha-Methoxizole Sulpha-methoxizole Sulphamethalazole Sulphamethoxazol Sulphamethoxazole Sulphamethoxazole BP 98 Sulphamethylisoxazole Sulphisomezole TL8005058 TMP/SMX (MIXTURE)) Trib UNII-JE42381TNV Urobak WLN: T5NOJ C1 EMSWR DZ ZINC00089763 nchembio.221-comp24 sulfamethoxazole |
| | 27 | | Trimethoprim | approved, vet_approved | Phase 4, Phase 3 | 173 | 738-70-5 | 5578 | 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine 46984_FLUKA 46984_RIEDEL 5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine 738-70-5 92131_FLUKA 92131_SIGMA AB00052118 AB1004879 AC-13572 AC1L1KNQ AC1Q48DF AI3-52594 AKOS001650069 ARONIS24118 AZT + TMP/SMX (mixture) combination Abacin Abaprim Alcorim-F Alprim Anitrim Antrima Antrimox Apo-Sulfatrim BB_SC-2116 BIDD:GT0190 BPBio1_000215 BRD-K07208025-001-06-5 BRN 0625127 BSPBio_000195 BSPBio_002245 BW 56-72 BW 5672 BW-56-72 Bacdan Bacidal Bacide Bacin Bacta Bacterial Bacterial [Antibiotic] Bacticel Bactin Bactoprim Bactramin Bactrim Bactrim DS Bactrim Pediatric Baktar Bencole Bethaprim Biosulten Briscotrim C01965 CAS-738-70-5 CCRIS 2410 CHEBI:45924 CHEMBL22 CID5578 CPD0-1581 CPD000035999 Chemotrim Chemotrin Cidal Co-Trimoxizole Co-trimoxazole Colizole Colizole DS Comox Conprim Cotrim Cotrim D.S. Cotrimel D00145 D014295 DB00440 Deprim DivK1c_000589 Drylin Duocide EINECS 212-006-2 EU-0101271 Esbesul Espectrin Euctrim Eusaprim Exbesul Fectrim Fermagex Fortrim Futin Gantaprim Gantrim HMS1568J17 HMS1921I03 HMS2090D14 HMS2092A10 HMS501N11 HSDB 6781 I06-0086 IDI1_000589 Idotrim Ikaprim Imexim Instalac Ipral KBio1_000589 KBio2_000647 KBio2_003215 KBio2_005783 KBio3_001465 KBioGR_000863 KBioSS_000647 KSC-4-158 KUC103659N Kepinol Kombinax LS-1627 Lagatrim Lagatrim Forte Laratrim Lastrim Lidaprim Linaris Lopac-T-7883 Lopac0_001271 MLS000079023 MLS001201740 MLS002303068 Methoprim Metoprim Microtrim MolPort-001-826-685 Monoprim Monotrim Monotrimin NCGC00016055-01 NCGC00016055-02 NCGC00016055-06 NCGC00016055-12 NCGC00024707-01 NCGC00024707-03 NCGC00024707-04 NCGC00024707-05 NCGC00024707-06 NCGC00024707-07 NCGC00024707-08 NIH 204 | NIH 204 (VAN) NINDS_000589 NSC 106568 NSC-106568 NSC106568 Nopil Novotrimel Omstat Oprea1_495058 Oraprim Pancidim Polytrim Prestwick0_000208 Prestwick1_000208 Prestwick2_000208 Prestwick3_000208 Prestwick_485 Priloprim Primosept Primsol Proloprim Proloprim (TN) Protrin Purbal Resprim Resprim Forte Roubac Roubal SAM002264649 SMP2_000262 SMR000035999 SPBio_000874 SPBio_002116 SPECTRUM1500595 STK177322 Salvatrim Septra Septra DS Septra Grape Septrin Septrin DS Septrin Forte Septrin S Setprin Sigaprim Sinotrim Smz-Tmp Spectrum2_000937 Spectrum3_000643 Spectrum4_000372 Spectrum5_001559 Spectrum_000167 Stopan Streptoplus Sugaprim Sulfamar Sulfamethoprim Sulfamethoprim-DS Sulfamethoxazole & Trimethoprim Sulfatrim Sulfatrim Pediatric Sulfatrim-DS Sulfatrim-SS Sulfotrim Sulfoxaprim Sulmeprim Sulmeprim Pediatric Sulprim Sulthrim Sultrex Sumetrolim Supracombin Suprim Syraprim T 7883 T2286 T7883_SIGMA TCMDC-125538 TL8005108 TMP/SMX (MIXTURE)) Teleprim Thiocuran Tiempe Tmp-Ratiopharm Tocris-0650 Toprim Trigonyl Trimanyl Trimesulf Trimeth/Sulfa Trimethioprim Trimethopim(TMP) Trimethoprim Trimethoprim & VRC3375 Trimethoprim (JAN/USP/INN) Trimethoprim [USAN:BAN:INN:JAN] Trimethoprime Trimethoprime [INN-French] Trimethoprimum Trimethoprimum [INN-Latin] Trimethopriom Trimetoprim Trimetoprim [DCIT] Trimetoprim [Polish] Trimetoprima Trimetoprima [INN-Spanish] Trimexazole Trimexol Trimez-IFSA Trimezol Trimogal Trimono Trimopan Trimpex Trimpex (TN) Trimpex 200 Triméthoprime Triprim Trisul Trisulcom Trisulfam Trisural U-Prin UNII-AN164J8Y0X UPCMLD-DP132 UPCMLD-DP132:001 Unitrim Uretrim Uro-D S Uro-Septra Urobactrim Uroplus Uroplus DS Uroplus SS Utetrin Velaten WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1 WR 5949 Wellcoprim Wellcoprin Xeroprim ZINC06627681 Zamboprim component of Bactrim component of Septra nchembio.108-comp1 nchembio.215-comp11 nchembio.221-comp23 trimethoprim | |
| | 28 | | Clindamycin | approved, vet_approved | Phase 4 | 168 | 18323-44-9 | 29029 | 13441-63-9 16669-21-9 18323-44-9 21462-39-5 (mono-hydrochloride) 24620-78-8 24696-19-3 58207-19-5 7(S)-Chloro-7-deoxylincomycin 7-CDL 7-Chloro-7-deoxylincomycin 7-Chlorolincomycin 7-Deoxy-7(S)-chlorolincomycin AC1L1EGQ AC1L1GLA AC1L9JV8 AC1MHD7N AC1MHE1M AC1MHUOE AC1MHX4G AC1NWAKO AC1O7ENS AC1O7GED AC1OFCIP AC1OFCIV AC1OFCJ1 AC1OFCJ7 AC1OIBYJ AC1OIBYL AC1OIBYN AC1Q2V4O Antirobe BIDD:GT0418 BPBio1_000236 BRD-A23034328-003-03-4 BSPBio_000214 BSPBio_002049 C06914 C18H33ClN2O5S CAS-21462-39-5 CHEBI:3745 CHEMBL187 CID2786 CID29029 CID3000512 CID3001928 CID3032758 CID3034218 CID446598 CID5702026 CID6602476 CID6604361 CID7048642 CID7048644 CID7048646 CID7048648 CID7276014 CID7276016 CID7276018 CID9812677 CLDM CLINDA & IL-12 CLY Chlolincocin Chlorlincocin Chlorodeoxylincomycin Chlorolincomycin Cleocin Cleocin (TN) Cleocin (tn) Cleocin HCl Cleocin Hcl Cleocin Pediatric Cleocin Phosphate Cleocin T Cleocin T Gel Cleocin T Lotion Cleocin T Topical Solution | Clinda-Derm ClindaDerm Clindagel Clindamicina Clindamicina [INN-Spanish] Clindamycin Clindamycin & Interleukin 12 Clindamycin & VRC3375 Clindamycin (USAN/INN) Clindamycin Hcl Clindamycin Hydrochloride Clindamycin Phosphate Clindamycin [USAN:BAN:INN] Clindamycine Clindamycine [French] Clindamycine [INN-French] Clindamycinum Clindamycinum [INN-Latin] Clindesse Clindets Clinimycin D00277 DB01190 Dalacin Dalacin C Dalacin C Flavored Granules Dalacin C Phosphate Dalacin T Topical Solution Dalacine DivK1c_000464 EINECS 242-209-1 Evoclin HMS2089A05 HMS2089N16 HSDB 3037 I06-0826 IDI1_000464 KBio1_000464 KBio2_000638 KBio2_003206 KBio2_005774 KBio3_001269 KBioGR_000844 KBioSS_000638 Klimicin Klindan 300 LS-187128 LS-98131 MLS001183714 Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside MolPort-002-323-206 MolPort-002-964-479 NCGC00016752-01 NCGC00178843-01 NCGC00179636-01 NINDS_000464 Prestwick0_000137 Prestwick1_000137 Prestwick2_000137 Prestwick3_000137 ResiDerm A SMP2_000295 SMR000677917 SPBio_000670 SPBio_002153 STK177246 STOCK1N-31150 Sobelin Spectrum2_000885 Spectrum3_000355 Spectrum4_000292 Spectrum5_001525 Spectrum_000158 U 21251 U-21,251 U-21251 UNII-3U02EL437C Zindaclin clindamycin |
| | 29 | | Sevoflurane | approved, vet_approved | Phase 4 | 479 | 28523-86-6 | 5206 | 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane 28523-86-6 AC-15484 AC1L1JU0 BRN 2041023 Bax 3084 C009250 C07520 C4H3F7O CHEBI:9130 CHEMBL1200694 CID5206 D00547 DB01236 F0691 Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether I14-13357 LS-67851 MR6S4 | MR_6S4 MolPort-001-775-746 NCGC00167421-01 PC4681 Sevofluran Sevoflurane Sevoflurane (JAN/USAN/INN) Sevoflurane [USAN:INN:BAN:JAN] Sevoflurano Sevoflurano [INN-Spanish] Sevofluranum Sevofluranum [INN-Latin] Sevofrane Sevorane Sojourn UNII-38LVP0K73A Ultane Ultane (TN) ZINC01530810 fluoromethyl hexafluoroisopropyl ether fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether sevoflurane |
| | 30 | | Sofosbuvir | approved | Phase 4 | 228 | 1190307-88-0 | 45375808 | S)-Isopropyl 2-((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4- dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)- (phenoxy)phosphorylamino)propanoate SOVALDI | |
| | 31 | | Ledipasvir | approved | Phase 4 | 97 | 1256388-51-8 | 67505836 | methyl [(2S)-1-{(6S)-6-[4-(9,9-difluoro-7-{2-[(1R,3S,4S)-2-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-azabicyclo[2.2.1]hept-3-yl]-1H-benzimidazol-5-yl}-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]hept-5-yl}-3-methyl-1-oxobutan-2-yl]carbamate | |
| | 32 | | Morphine | approved, investigational | Phase 4 | 960 | 57-27-2 | 5288826 | (-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (-)-Heroin hydrochloride (-)-Morphine (-)Morphine sulfate (5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol (5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol (5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol (5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL (7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol (−)-morphine 17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol 4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol 4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol 47106-99-0 57-27-2 6211-15-0 (sulfate (2:1) (salt) pentahydrate) 64-31-3 64-31-3 (sulfate (2:1) (salt) anhydrous) 7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol 7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol 8053-16-5 85201-37-2 Apokyn Astramorph PF Avinza BIDD:GT0147 C01516 CCRIS 5762 CHEBI:17303 CHEMBL70 CID5288826 Cube juice D-(-)-Morphine DB00295 DEA No. 9300 DepoDur Depodur Diacetylmorphine hydrochloride Diamorphine hydrochloride Dolcontin Dreamer Dulcontin Duramorph PF Duromorph EINECS 200-320-2 Epimorph HSDB 2134 Hard stuff Heroin hydrochloride Heroine hydrochloride Hocus | Infumorph Kadian LS-91748 M-Eslon M.O.S MOI MORPHINE SULFATE MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE MS Contin MS/L MS/S MSIR Meconium MolPort-003-849-273 Morfina Morfina [Italian] Morphia Morphin Morphin [German] Morphina Morphina [Italian] Morphine Extra-Forte Morphine Forte Morphine H.P Morphine Sulfate Morphine [BAN] Morphinism Morphinum Morphitec Morphium Morpho Moscontin Ms Contin Ms Emma NSC11441 Nepenthe O,O'-Diacetylmorphine hydrochloride OMS Concentrate Oramorph SR Ospalivina RMS RMS Uniserts Rescudose Roxanol Roxanol 100 Roxanol UD SDZ 202-250 SDZ202-250 Statex Statex Drops Statex SR UNII-76I7G6D29C Unkie l-Morphine morfina morphine nchembio.317-comp1 nchembio.64-comp1 |
| | 33 | | Deferiprone | approved | Phase 4 | 57 | 30652-11-0 | 2972 | 1,2-Dimethyl-3-hydroxypyrid-4-one 3-Hydroxy-1,2-dimethyl-4(1H)-pyridone APO-066 CP-20 DN-180-01-AF Deferipron | Deferiprona Deferiproni Deferipronum Deferypron Dimethylhydroxypyridone Défériprone Ferriprox PL-1 |
| | 34 | | Calcium carbonate | approved | Phase 4 | 208 | 471-34-1 | | CaCO3 Calcium carbonate Calcium carbonate (1:1) Calciumcarbonat Carbonate de calcium | Carbonato de calcio Carbonic acid calcium salt (1:1) E 170 Kalziumkarbonat Kohlensaurer kalk Precipitated calcium carbonate | |
| | 35 | | Acetylcholine | approved | Phase 4 | 776 | 51-84-3 | 187 | ACh Acetyl choline ion Acetylcholine Chloride Acetylcholine cation | Acetylcholinium: acetyl-Choline Choline acetate Choline acetate (ester) O-Acetylcholine acetylcholine chloride | |
| | 36 | | Folic Acid | approved, nutraceutical, vet_approved | Phase 4, Phase 3, Phase 2 | 4279 | 59-30-3 | 6037 | (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid 01769_FLUKA 2d0k 33609-88-0 36653-55-1 (mono-potassium salt) 59-30-3 6484-89-5 (mono-hydrochloride salt) AC-11682 AC1L1LNX AI3-26387 AKOS000503224 ARONIS014410 Acfol (Spain) Acide folique Acide folique [INN-French] Acido folico Acido folico [INN-Spanish] Acidum folicum Acidum folicum [INN-Latin] Acifolic Antianemia factor Apo-Folic BIDD:ER0563 BIDD:GT0641 BIF0608 BPBio1_000654 BSPBio_000594 BSPBio_002338 C00504 C20H20N6O6 CAS-59-30-3 CCRIS 666 CHEBI:27470 CHEMBL1622 CID6037 CPD000471860 Cytofol D00070 DB00158 DivK1c_000494 Dosfolat B activ EINECS 200-419-0 F0043 F7876_SIAL F7876_SIGMA F8758_SIGMA F8798_SIAL F8890_SIGMA FOL Facid Factor U Folacid Folacin Folaemin Folaemin [Netherlands] Folan Folasic (Australia) Folate Folbal Folcidin Folcidin (VAN) Folcysteine Foldine Foldine [France] Folettes Foliamin Folic Folic acid Folic acid (JP15/USP/INN) Folic acid (TN) Folic acid [BAN:INN:JAN] Folic acid [INN:BAN:JAN] Folic acid dihydrate Folicet Folicet (TN) Folico Folico (Italy) Folina Folina (Italy) Folipac Folsaeure | Folsan Folsaure Folsav Folvite Folvron Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L HMS1921D20 HMS2092N17 HMS501I16 HSDB 2002 IDI1_000494 InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s Incafolic KBio1_000494 KBio2_001861 KBio2_004429 KBio2_006997 KBio3_001558 KBioGR_002222 KBioSS_001861 Kyselina listova Kyselina listova [Czech] LS-2157 Liver Lactobacillus casei factor MLS001304016 MLS001335861 Millafol Mission prenatal Mittafol MolPort-004-285-551 N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-Pteroyl-L-glutamic acid N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid NCGC00016265-01 NCGC00142391-01 NINDS_000494 NSC 3073 Nifolin Nifolin [Denmark] Novofolacid Novofolacid [Canada] PGA PGA (VAN) Prestwick3_000627 Prestwick_230 PteGlu Pteroyl-L-glutamate Pteroyl-L-glutamic acid Pteroyl-L-monoglutamate Pteroyl-L-monoglutamic acid Pteroylglutamate Pteroylglutamic acid Pteroylmonoglutamate Pteroylmonoglutamic acid SAM002264616 SDCCGMLS-0066738.P001 SMP2_000137 SMR000471860 SPBio_001357 SPECTRUM1502020 Serum Folate Level Spectrum2_001459 Spectrum3_000749 Spectrum4_001751 Spectrum5_000602 Spectrum_001381 UNII-935E97BOY8 Usaf cb-13 Vitamin B11 Vitamin B9 Vitamin Bc Vitamin Be Vitamin M bmse000299 folic acid nchembio.108-comp10 | |
| | 37 | | tannic acid | approved, Nutraceutical | Phase 4, Phase 2, Phase 3, Phase 1 | 1892 | | | | 38 | | Pirfenidone | investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 49 | 53179-13-8 | 40632 | 5-21-07-00197 (Beilstein Handbook Reference) 5-Methyl-1-phenyl-1H-pyridin-2-one 5-Methyl-1-phenyl-2(1H)-pyridone 5-Methyl-1-phenyl-2-(1H)-pyridone 5-methyl-1-phenylpyridin-2(1H)-one 5-methyl-1-phenylpyridin-2-one 53179-13-8 AC-6797 AC1L2454 AMR 69 AMR-69 BRD-K96862998-001-03-1 BRN 1526549 Bio1_000397 Bio1_000886 Bio1_001375 C093844 C12H11NO CID40632 D01583 Deskar EN000704 EU-0100907 Esbriet F-647 FT-0082541 | I01-1466 KS-5041 LS-133834 Lopac-P-2116 Lopac0_000907 MLS000860042 NCGC00015806-01 NCGC00015806-03 NCGC00015806-05 NCGC00024992-01 NCGC00024992-02 NCGC00024992-03 P 2116 P2116_SIGMA PIRFENIDONE Pirespa Pirfenidona Pirfenidona [INN-Spanish] Pirfenidone (Deskar) Pirfenidone (JAN/USAN/INN) Pirfenidone [USAN:INN] Pirfenidonum Pirfenidonum [INN-Latin] S-7701 SMR000326900 Tocris-1093 ZINC00001958 | |
| | 39 | | Neuroprotective Agents | | Phase 4, Phase 2, Phase 3 | 1672 | | | | 40 | | Antineoplastic Agents, Hormonal | | Phase 4, Phase 3, Phase 2, Phase 1 | 5407 | | | | 41 | | Gastrointestinal Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 8109 | | | | 42 | | Autonomic Agents | | Phase 4, Phase 2, Phase 3, Phase 1 | 9774 | | | | 43 | | Analgesics | | Phase 4, Phase 3, Phase 2, Phase 1 | 11287 | | | | 44 | | Anti-Inflammatory Agents, Non-Steroidal | | Phase 4, Phase 3, Phase 2, Phase 1 | 4295 | | | | 45 | | Analgesics, Non-Narcotic | | Phase 4, Phase 3, Phase 2, Phase 1 | 6260 | | | | 46 | | Neurotransmitter Agents | | Phase 4, Phase 2, Phase 1 | 17734 | | | | 47 | | Antiparasitic Agents | | Phase 4, Phase 3, Phase 2 | 2127 | | | | 48 | | Antiprotozoal Agents | | Phase 4, Phase 3, Phase 2 | 1986 | | | | 49 | | Antiviral Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 9732 | | | | 50 | | Antineoplastic Agents, Alkylating | | Phase 4, Phase 3, Phase 2, Phase 1 | 4474 | | |
Interventional clinical trials: (show top 50)
(show all 617)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study | Unknown status | NCT00637065 | Phase 4 | | 2 | Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil | Unknown status | NCT00625079 | Phase 4 | | 3 | Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan | Unknown status | NCT00625469 | Phase 4 | | 4 | Acute Effect of Sildenafil on Exercise Tolerance and Functional Capacity in COPD, IPF and Post Pneumonectomy Patients | Unknown status | NCT01382368 | Phase 4 | | 5 | Fibrosis in Renal Allografts | Unknown status | NCT00493194 | Phase 4 | | 6 | Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis | Unknown status | NCT02169219 | Phase 4 | | 7 | Alemtuzumab for ANCA Associated Refractory Vasculitis | Unknown status | NCT01405807 | Phase 4 | | 8 | Surfactant Administration During Spontaneous Breathing | Unknown status | NCT01329432 | Phase 4 | | 9 | Pulmonary Rehabilitation in Interstitial Lung Diseases | Completed | NCT00882817 | Phase 4 | | 10 | Iressa Case Control Study in Japan | Completed | NCT00252759 | Phase 4 | | 11 | Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension | Completed | NCT00403650 | Phase 4 | | 12 | Fractionated Versus Target-controlled Propofol Administration in Bronchoscopy | Completed | NCT02246023 | Phase 4 | | 13 | Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years | Completed | NCT00307671 | Phase 4 | | 14 | An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study) | Completed | NCT01736540 | Phase 4 | | 15 | Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication | Completed | NCT02246361 | Phase 4 | | 16 | Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep | Recruiting | NCT02150616 | Phase 4 | | 17 | Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance | Recruiting | NCT02143687 | Phase 4 | | 18 | Palliation of Dyspnea With Morphine in Patients With Interstitial Lung Disease | Recruiting | NCT02622022 | Phase 4 | | 19 | Hepatitis C Virus(HCV) Heart and Lung Study | Recruiting | NCT02858180 | Phase 4 | | 20 | Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx) | Recruiting | NCT02286063 | Phase 4 | | 21 | A Study to Compare the Amount of Nintedanib and Pirfenidone in the Blood When Nintedanib and Pirfenidone Are Given Separately or in Combination | Recruiting | NCT02606877 | Phase 4 | | 22 | Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment | Recruiting | NCT02788474 | Phase 4 | | 23 | Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada | Recruiting | NCT02552849 | Phase 4 | | 24 | Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) | Recruiting | NCT02598193 | Phase 4 | | 25 | Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS) | Recruiting | NCT02188017 | Phase 4 | | 26 | Low-dose Glucocorticoid Vasculitis Induction Study | Recruiting | NCT02198248 | Phase 4 | | 27 | A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis | Recruiting | NCT02115997 | Phase 4 | | 28 | Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS) | Recruiting | NCT01763853 | Phase 4 | | 29 | Novartis Everolimus Transition | Active, not recruiting | NCT02096107 | Phase 4 | | 30 | Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF | Active, not recruiting | NCT02579603 | Phase 4 | | 31 | Observational Study of Deferiprone (Ferriprox®) in the Treatment of Superficial Siderosis | Active, not recruiting | NCT01284127 | Phase 4 | | 32 | Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis | Not yet recruiting | NCT02821689 | Phase 4 | | 33 | Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome | Not yet recruiting | NCT02370550 | Phase 4 | | 34 | Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis | Not yet recruiting | NCT02626845 | Phase 4 | | 35 | Albumin in Cardiac Surgery | Not yet recruiting | NCT02560519 | Phase 4 | | 36 | Study of Nicotine Patches in Patients With Sarcoidosis | Suspended | NCT00701207 | Phase 4 | | 37 | 68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis | Terminated | NCT01321996 | Phase 4 | | 38 | Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") | Terminated | NCT00747461 | Phase 4 | | 39 | Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP) | Withdrawn | NCT00636935 | Phase 4 | | 40 | Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension | Unknown status | NCT00705133 | Phase 3 | | 41 | Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection | Unknown status | NCT00841750 | Phase 3 | | 42 | Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study | Unknown status | NCT00203697 | Phase 3 | | 43 | Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis | Unknown status | NCT00439543 | Phase 2, Phase 3 | | 44 | Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus | Unknown status | NCT00504348 | Phase 2, Phase 3 | | 45 | Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis | Unknown status | NCT00981747 | Phase 2, Phase 3 | | 46 | Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer | Unknown status | NCT00349102 | Phase 3 | | 47 | Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) | Unknown status | NCT00103792 | Phase 3 | | 48 | WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides | Unknown status | NCT00349674 | Phase 3 | | 49 | Study of Ablation for the Pulmonary Focal Pure Ground Glass Opacity (pGGO) | Unknown status | NCT01429649 | Phase 3 | | 50 | A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma | Completed | NCT01553981 | Phase 3 |
|
